InvestorsObserver
×
News Home

Where Will Chinook Therapeutics Inc (KDNY) Stock Go Next After It Is Higher By 3.07% in a Week?

Tuesday, August 01, 2023 12:37 PM | InvestorsObserver Analysts

Mentioned in this article

Where Will Chinook Therapeutics Inc (KDNY) Stock Go Next After It Is Higher By 3.07% in a Week?

Overall market sentiment has been high on Chinook Therapeutics Inc (KDNY) stock lately. KDNY receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
Chinook Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on KDNY!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With KDNY Stock Today?

Chinook Therapeutics Inc (KDNY) stock is higher by 2.82% while the S&P 500 has fallen -0.41% as of 12:36 PM on Tuesday, Aug 1. KDNY is up $1.10 from the previous closing price of $39.18 on volume of 6,207,042 shares. Over the past year the S&P 500 is higher by 10.96% while KDNY is up 121.20%. KDNY lost -$3.19 per share in the over the last 12 months. To screen for more stocks like Chinook Therapeutics Inc click here.

More About Chinook Therapeutics Inc

Chinook Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing precision medicines for kidney diseases. The products of the company are focused on rare, severe chronic kidney disorders. Click Here to get the full Stock Report for Chinook Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App